Tag Archives: Remdesivir

Were Lives Lost Because Of Politics And Greed?

Posted on by

I think it’s time to ask if the political games the media played during the Trump administration and the conflict of interest in some members of the National Institute of Health resulted in the deaths of Americans. Hot Air posted an article today about s recent study on the use of hydroxychloroquine (HCQ) to treat Covid patients.

The article reports:

For most of us, the whole controversy over the use of hydroxychloroquine in treating COVID-19 patients seemed mostly political in nature and less so about the drug’s effectiveness. Once Donald Trump came out in support of it, the gloves came off. At least half of the country decided that HCQ was not a scientific treatment for the coronavirus because the bad Orange Man was an anti-science president. Never mind that it was Trump who expedited the vaccine process to historic speed with Operation Warp Speed. He put together a White House coronavirus task force before many people (especially on the left) were willing to acknowledge the pandemic that originated in China. When Trump announced that he was taking HCQ himself, he was roundly mocked. Nevertheless, others in the medical community studied the use of the drug during the pandemic and found some positive results.

The article notes that hydroxychloroquine costs under $10 for the course of a COVID-19 treatment and the drug being promoted by the National Institute of Health (NIH) during the Trump administration, remdesivir, costs about $3,500 per treatment. Hydroxychloroquine has been used for years with known side effects. The side effects of remdesivir are unknown.

The article suggests we follow the money and continues with the following excerpt from The Washington Times:

Although, many doctors around the world were finding success with HCQ, in February 2020 NIH started enrolling patients for a remdesivir COVID-19 trial, with Dr. Fauci overseeing its progress. He had the final say on all the press releases, and presumably was working closely with Gilead. On April 16 something funny happened with the trial — the endpoints of it were quietly changed and updated on the clinicaltrials.gov website. Instead of evaluating remdesivir’s ability to prevent death from COVID-19, the study was redesigned to evaluate how fast a patient recovered from remdesivir.

…On May 1, the NIH’s COVID-19 Treatment Guidelines panel members granted emergency use of remdesivir and stated HCQ could only be used in hospitals or in studies. Investigative journalist Sharyl Attkisson found 11 members of that panel had financial ties to Gilead. Two were on Gilead’s advisory board, others were paid consultants or received research support and honoraria. None of the members, however, had ties to HCQ, which is made by numerous generic manufacturers, and “is so cheap, analysts say even a spike in sales would not be a financial driver for the companies,” Ms. Attkisson reported.

Ms. Attkisson also found one of the authors of a small Veterans Administration trial that claimed HCQ caused increased deaths received a $247,000 grant from Gilead in 2018.

The article at Hot Air concludes:

You may remember that when Trump was hospitalized with COVID-19, he was treated with remdesivir and did, indeed, experience a speedy recovery. By the way, Gilead spent $2.45 million in the first quarter of 2020 lobbying the federal government.

The results of the latest study showing success with HCQ in patient recovery time for those on a ventilator is very encouraging. Perhaps the Follow the Science people should practice what they preach. How many lives were lost because of tunnel vision?

This is disgusting. All of the members of the NIH who had ties to Gilead should be fired. Lives were lost because they were greedy.

This Explains A Lot

Posted on by

Yesterday Just the News posted an article about the members of the National Institutes of Health’s COVID-19 Treatment Guidelines Panel. It seems as if they have allowed their financial interests to interfere with the interests of the Americans who have contracted the coronavirus.

The article reports:

Members of the National Institutes of Health’s COVID-19 Treatment Guidelines Panel have financial ties to a company behind clinical trials of a drug to treat coronavirus, as well as to another large pharmaceutical company involved with developing a COVID-19 vaccine.

According to the NIH, members of the panel include U.S. physicians, statisticians, and other experts who are developing treatment guidelines on COVID-19 “intended for healthcare providers.”

A total of eight panel members list a financial relationship with Gilead Sciences on the panel’s Financial Disclosure for Companies Related to COVID-19 Treatment or Diagnostics document: Judith Aberg, MD, Adaora Adimora, MD, Jason Baker, MD, Roger Bedimo, MD, Eric Daar, MD, David V. Glidden, PhD, Susanna Naggie, MD, and Pablo Tebas, MD.  

The U.S. has reportedly bought almost all of Gilead Sciences’ supply of the COVID-19 drug remdesivir. The company announced on June 1 the results of a phase 3 clinical trial of the drug in patients with moderate COVID-19.

On Monday, Gilead applied for FDA approval of remdesivir, which has been available for emergency use with patients hospitalized with severe cases of COVID-19.

The article notes:

Dr. William O’Neill, a cardiologist and Medical Director at the Henry Ford Health System in Detroit, Mich., told Just the News contributor Sharyl Attkisson in an interview for her news program “Full Measure” that he is less impressed with remdesivir.

“There is a lot of hype for the drug,” said O’Neil, adding that he sees “no big benefit” to remdesivir after reading medical journal reports on it.  

This appears to be a blatant example of ‘follow the money’ resulting in Americans dying from the coronavirus because of pressure to block using hydroxychloroquine. It should be noted that remdesivir costs thousands of dollars for one pill and hydroxychloroquine costs less than a dollar for one pill. It’s sad to think that doctors would behave so badly, but it appears that they have.

There Seems To Be A Conflict Of Interest Here

Posted on by

The Gateway Pundit posted an article today that may explain why Dr. Fauci is promoting remdesivir and downplaying the success of hydroxychloroquine.

It seems that remdesivir has some very interesting connections. Gilead Sciences is the company that produces remdesivir.

The article explains:

And just who, or what is Gilead Sciences? Gilead is partnered with Wuxi AppTec, an international pharmaceutical, biopharmaceutical and medical device company. According to Wikipedia, “The company covers the development cycle through five core operations, including small molecule R&D and manufacturing, biologics R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, medical device testing, and molecular testing and genomics.” And where, you may ask, is the company located? Wuxi AppTec was begun in Shanghai by Dr. Gi Li now with facilities also in Wuxi City and Suzhou, China, as well as facilities in St. Paul, Minnesota, Philadelphia and Atlanta. Wuxi AppTec is owned in part by none other than America’s own – George Soros.

Follow the money.

The article includes the following:

The article continues:

In addition, WND reports Gilead is related to UNITAID:

Holding this web together is the fact that Gilead has endorsed and is engaged with a drug purchasing group, UNITAID. UNITAID is an outgrowth of the United Nations, Millennium Declaration of 2000, which is now the U.N. Global Compact.

The large investors in UNITAID include WHO, George Soros, the Bill and Melinda Gates Foundation and a partnership relationship with the Clinton Health Access Initiative. Both Drs. Fauci and Birx are associated with the Clinton Health Access Initiative.

The one person behind the promotion of Gilead’s remdesivir is the doctor who has worked with Gilead for a long time, Dr. Fauci.  He also has downplayed and criticized the use of the much cheaper drug hydroxychloroquine:

Can there be any uncertainty as to why Dr. Fauci, who worked closely with Gilead, is strongly promoting its more expensive and less effective medication, which has already failed against Ebola, over a readily available, markedly affordable medication with a 91% success rate?

How long has the production of remdesivir been in the planning?  Why is this drug so highly touted by Dr. Fauci?  The answer appears to be related to Gilead Sciences.

These connections might explain a lot.

 

Things That Are Beginning To Add Up

Posted on by

Yesterday the U.K. Daily Mail reported that on January 21, 2020, China filed a patent for Remdesivir, one of the drugs being used to treat the coronavirus. January 21st was the day after China confirmed human transmission of the disease.

The article reports:

The revelation that it moved so fast fuels concerns about a cover-up of the pandemic when it erupted in Wuhan last year, and suggests that China’s understanding of the virus was far advanced from the impression given by its public stance.

Last night, Tom Tugendhat, chairman of the Foreign Affairs Select Committee, joined the growing global clamour for a full, independent inquiry into China’s role.

‘It is quite clear there is an awful lot that we don’t know about the emergence of this disease and the responses to it,’ he said. ‘We all need to learn the lessons of the outbreak so the international community can respond better in the future.’

China’s Communist Party leaders face accusations that they suppressed data, blocked public health teams from investigating, silenced doctors seeking to warn the world about the epidemic and delayed admitting there was human transmission.

We need to remember that in dealing with China, we are dealing with a closed society. The people of China either say and do what the government tells them to say or do or they wind up dead, missing, or in re-education camps. China is in no way a free society, and the information they put out cannot be trusted.

The article concludes:

Professor Martin Landray, a leader of the Oxford study, said doctors would probably end up with a range of drugs to fight the virus, adding: ‘It is unlikely we will get a wonder drug that will knock out the infection.’

Prof Landray said drugs might be used in combinations to help reduce death rates.

He added: ‘Even if you find a drug that reduces the death rate by one fifth, that would have meant we would have been able to save about 4,000 lives already in Britain.’

We need a reliable cure for the coronavirus more than we need a vaccination or a lockdown.